Carina Biotech Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.5M

  • Investors
  • 5

Carina Biotech General Information

Description

Developer of a broad-spectrum chimeric antigen receptor T-cell technology designed to treat solid cancers, including pediatric and rare cancers. The company's platform develops T-cell therapy, which involves engineering a patient's own immune system to target and destroy their cancer cells, enabling doctors to use the therapy for the treatment of a broad range of cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Level 2, Ian Wark (IW) Building
  • UniSA Mawson Lakes Campus
  • Mawson Lakes, South Australia 5095
  • Australia
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Level 2, Ian Wark (IW) Building
  • UniSA Mawson Lakes Campus
  • Mawson Lakes, South Australia 5095
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carina Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 14-Aug-2022 $7.5M Completed Clinical Trials - Phase 1
6. Later Stage VC 30-Aug-2021 Completed Clinical Trials - Phase 1
5. Grant 23-Apr-2020 Completed Clinical Trials - Phase 1
4. Accelerator/Incubator 01-Jan-2020 Completed Clinical Trials - Phase 1
3. Grant 31-Jul-2018 Completed Clinical Trials - Phase 1
2. Grant 30-Jul-2018 $1.7M $1M Completed Clinical Trials - Phase 1
1. Accelerator/Incubator 20-Apr-2018 $1M $1M Completed Clinical Trials - Phase 1
To view Carina Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Carina Biotech Patents

Carina Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022903762-A0 Methods for diagnosing and treating ovarian cancer Inactive 09-Dec-2022
WO-2024119233-A1 Methods for diagnosing and treating ovarian cancer Inactive 09-Dec-2022
AU-2021900687-A0 Methods for purifying t cells Inactive 10-Mar-2021
AU-2020904256-A0 Chimeric antigen receptor t cell and method Inactive 18-Nov-2020
CA-3202371-A1 Chimeric antigen receptor t cell and method Pending 18-Nov-2020 A61K40/4202
To view Carina Biotech’s complete patent history, request access »

Carina Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carina Biotech Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Southern Angels Angel Group Minority
Tenmile Venture Capital Minority
Minderoo Foundation Not-For-Profit Venture Capital Minority
University of Adelaide Endowment Limited Partner
Innovation and Collaboration Centre Accelerator/Incubator
To view Carina Biotech’s complete investors history, request access »

Carina Biotech FAQs

  • When was Carina Biotech founded?

    Carina Biotech was founded in 2016.

  • Where is Carina Biotech headquartered?

    Carina Biotech is headquartered in Mawson Lakes, Australia.

  • What is the size of Carina Biotech?

    Carina Biotech has 17 total employees.

  • What industry is Carina Biotech in?

    Carina Biotech’s primary industry is Biotechnology.

  • Is Carina Biotech a private or public company?

    Carina Biotech is a Private company.

  • What is Carina Biotech’s current revenue?

    The current revenue for Carina Biotech is .

  • How much funding has Carina Biotech raised over time?

    Carina Biotech has raised $12.4M.

  • Who are Carina Biotech’s investors?

    Southern Angels, Tenmile, Minderoo Foundation, University of Adelaide Endowment, and Innovation and Collaboration Centre have invested in Carina Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process